Global Congestive Heart Failure (CHF) Treatment Devices Market Growth 2020-2025
According to this study, over the next five years the Congestive Heart Failure (CHF) Treatment Devices market will register a 3.2%% CAGR in terms of revenue, the global market size will reach $ 5523.1 million by 2025, from $ 4862.6 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Congestive Heart Failure (CHF) Treatment Devices business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Congestive Heart Failure (CHF) Treatment Devices market by product type, application, key manufacturers and key regions and countries.
This study specially analyses the impact of Covid-19 outbreak on the Congestive Heart Failure (CHF) Treatment Devices, covering the supply chain analysis, impact assessment to the Congestive Heart Failure (CHF) Treatment Devices market size growth rate in several scenarios, and the measures to be undertaken by Congestive Heart Failure (CHF) Treatment Devices companies in response to the COVID-19 epidemic.
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
Cardiac Resynchronization Therapy (CRT)
Implantable Cardioverter Defibrillators (ICDs)
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Left Ventricular Assist Device (LVAD)
Right Ventricular Assist Device (RVAD)
Biventricular Assist Device (BIVAD)
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Abiomed
Abbott
Berlin Heart GmbH
Boston Scientific Corporation
HeartWare International
Biotronik SE & Co. KG
Medtronic
Jarvik Heart
ReliantHeart
LivaNova PLC
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Congestive Heart Failure (CHF) Treatment Devices consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Congestive Heart Failure (CHF) Treatment Devices market by identifying its various subsegments.
Focuses on the key global Congestive Heart Failure (CHF) Treatment Devices manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Congestive Heart Failure (CHF) Treatment Devices with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Congestive Heart Failure (CHF) Treatment Devices submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption 2015-2025
2.1.2 Congestive Heart Failure (CHF) Treatment Devices Consumption CAGR by Region
2.2 Congestive Heart Failure (CHF) Treatment Devices Segment by Type
2.2.1 Cardiac Resynchronization Therapy (CRT)
2.2.2 Implantable Cardioverter Defibrillators (ICDs)
2.3 Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
2.3.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
2.3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue and Market Share by Type (2015-2020)
2.3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type (2015-2020)
2.4 Congestive Heart Failure (CHF) Treatment Devices Segment by Application
2.4.1 Left Ventricular Assist Device (LVAD)
2.4.2 Right Ventricular Assist Device (RVAD)
2.4.3 Biventricular Assist Device (BIVAD)
2.5 Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
2.5.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
2.5.2 Global Congestive Heart Failure (CHF) Treatment Devices Value and Market Share by Type (2015-2020)
2.5.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type (2015-2020)
3 Global Congestive Heart Failure (CHF) Treatment Devices by Company
3.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company
3.1.1 Global Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2018-2020)
3.1.2 Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2018-2020)
3.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company
3.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2018-2020)
3.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2018-2020)
3.3 Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Company
3.4 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Congestive Heart Failure (CHF) Treatment Devices Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Congestive Heart Failure (CHF) Treatment Devices by Regions
4.1 Congestive Heart Failure (CHF) Treatment Devices by Regions
4.2 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Growth
4.3 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Growth
4.4 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Growth
4.5 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Growth
5 Americas
5.1 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries
5.1.1 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020)
5.1.2 Americas Congestive Heart Failure (CHF) Treatment Devices Value by Countries (2015-2020)
5.2 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
5.3 Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Regions
6.1.1 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Regions (2015-2020)
6.1.2 APAC Congestive Heart Failure (CHF) Treatment Devices Value by Regions (2015-2020)
6.2 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
6.3 APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Congestive Heart Failure (CHF) Treatment Devices by Countries
7.1.1 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020)
7.1.2 Europe Congestive Heart Failure (CHF) Treatment Devices Value by Countries (2015-2020)
7.2 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
7.3 Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices by Countries
8.1.1 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value by Countries (2015-2020)
8.2 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Type
8.3 Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Congestive Heart Failure (CHF) Treatment Devices Distributors
10.3 Congestive Heart Failure (CHF) Treatment Devices Customer
11 Global Congestive Heart Failure (CHF) Treatment Devices Market Forecast
11.1 Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast (2021-2025)
11.2 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Regions
11.2.1 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Regions (2021-2025)
11.2.2 Global Congestive Heart Failure (CHF) Treatment Devices Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Type
11.8 Global Congestive Heart Failure (CHF) Treatment Devices Forecast by Application
12 Key Players Analysis
12.1 Abiomed
12.1.1 Company Information
12.1.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.1.3 Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Abiomed Latest Developments
12.2 Abbott
12.2.1 Company Information
12.2.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.2.3 Abbott Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Abbott Latest Developments
12.3 Berlin Heart GmbH
12.3.1 Company Information
12.3.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.3.3 Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Berlin Heart GmbH Latest Developments
12.4 Boston Scientific Corporation
12.4.1 Company Information
12.4.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.4.3 Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Boston Scientific Corporation Latest Developments
12.5 HeartWare International
12.5.1 Company Information
12.5.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.5.3 HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 HeartWare International Latest Developments
12.6 Biotronik SE & Co. KG
12.6.1 Company Information
12.6.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.6.3 Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Biotronik SE & Co. KG Latest Developments
12.7 Medtronic
12.7.1 Company Information
12.7.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.7.3 Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Medtronic Latest Developments
12.8 Jarvik Heart
12.8.1 Company Information
12.8.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.8.3 Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 Jarvik Heart Latest Developments
12.9 ReliantHeart
12.9.1 Company Information
12.9.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.9.3 ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 ReliantHeart Latest Developments
12.10 LivaNova PLC
12.10.1 Company Information
12.10.2 Congestive Heart Failure (CHF) Treatment Devices Product Offered
12.10.3 LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales, Revenue, Price and Gross Margin (2018-2020)
12.10.4 Main Business Overview
12.10.5 LivaNova PLC Latest Developments
13 Research Findings and Conclusion
Tables and Figures
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Congestive Heart Failure (CHF) Treatment Devices Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Players of Cardiac Resynchronization Therapy (CRT)
Table 5. Major Players of Implantable Cardioverter Defibrillators (ICDs)
Table 6. Global Consumption Sales by Type (2015-2020)
Table 7. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
Table 8. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Type (2015-2020) ($ million)
Table 9. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Type (2015-2020) ($ Millions)
Table 10. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Type (2015-2020)
Table 11. Global Consumption Sales by Application (2015-2020)
Table 12. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2015-2020)
Table 13. Global Congestive Heart Failure (CHF) Treatment Devices Value by Application (2015-2020)
Table 14. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Application (2015-2020)
Table 15. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Application (2015-2020)
Table 16. Global Congestive Heart Failure (CHF) Treatment Devices Sales by Company (2017-2019) (K Units)
Table 17. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company (2017-2019)
Table 18. Global Congestive Heart Failure (CHF) Treatment Devices Revenue by Company (2017-2019) ($ Millions)
Table 19. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company (2017-2019)
Table 20. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Company (2017-2019)
Table 21. Global Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base Distribution and Sales Area by Manufacturers
Table 22. Players Congestive Heart Failure (CHF) Treatment Devices Products Offered
Table 23. Congestive Heart Failure (CHF) Treatment Devices Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 24. Global Congestive Heart Failure (CHF) Treatment Devices Consumption by Regions 2015-2020 (K Units)
Table 25. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Regions 2015-2020
Table 26. Global Congestive Heart Failure (CHF) Treatment Devices Value by Regions 2015-2020 ($ Millions)
Table 27. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Regions 2015-2020
Table 28. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 29. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries (2015-2020)
Table 30. Americas Congestive Heart Failure (CHF) Treatment Devices Value by Countries (2015-2020) ($ Millions)
Table 31. Americas Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Countries (2015-2020)
Table 32. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 33. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
Table 34. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption by Application (2015-2020) (K Units)
Table 35. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2015-2020)
Table 36. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 37. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries (2015-2020)
Table 38. APAC Congestive Heart Failure (CHF) Treatment Devices Value by Regions (2015-2020) ($ Millions)
Table 39. APAC Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Regions (2015-2020)
Table 40. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 41. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
Table 42. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption by Application (2015-2020) (K Units)
Table 43. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2015-2020)
Table 44. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 45. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries (2015-2020)
Table 46. Europe Congestive Heart Failure (CHF) Treatment Devices Value by Countries (2015-2020) ($ Millions)
Table 47. Europe Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Countries (2015-2020)
Table 48. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 49. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
Table 50. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption by Application (2015-2020) (K Units)
Table 51. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2015-2020)
Table 52. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Countries (2015-2020) (K Units)
Table 53. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries (2015-2020)
Table 54. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value by Countries (2015-2020) ($ Millions)
Table 55. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Type (2015-2020) (K Units)
Table 57. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
Table 58. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption by Application (2015-2020) (K Units)
Table 59. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2015-2020)
Table 60. Congestive Heart Failure (CHF) Treatment Devices Distributors List
Table 61. Congestive Heart Failure (CHF) Treatment Devices Customer List
Table 62. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast by Countries (2021-2025) (K Units)
Table 63. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Forecast by Regions
Table 64. Global Congestive Heart Failure (CHF) Treatment Devices Value Forecast by Countries (2021-2025) ($ Millions)
Table 65. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share Forecast by Regions
Table 66. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast by Type (2021-2025) (K Units)
Table 67. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share Forecast by Type (2021-2025)
Table 68. Global Congestive Heart Failure (CHF) Treatment Devices Value Forecast by Type (2021-2025) ($ Millions)
Table 69. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share Forecast by Type (2021-2025)
Table 70. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Forecast by Application (2021-2025) (K Units)
Table 71. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share Forecast by Application (2021-2025)
Table 72. Global Congestive Heart Failure (CHF) Treatment Devices Value Forecast by Application (2021-2025) ($ Millions)
Table 73. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share Forecast by Application (2021-2025)
Table 74. Abiomed Product Offered
Table 75. Abiomed Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 76. Abiomed Main Business
Table 77. Abiomed Latest Developments
Table 78. Abiomed Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 79. Abbott Product Offered
Table 80. Abbott Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 81. Abbott Main Business
Table 82. Abbott Latest Developments
Table 83. Abbott Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 84. Berlin Heart GmbH Product Offered
Table 85. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 86. Berlin Heart GmbH Main Business
Table 87. Berlin Heart GmbH Latest Developments
Table 88. Berlin Heart GmbH Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 89. Boston Scientific Corporation Product Offered
Table 90. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 91. Boston Scientific Corporation Main Business
Table 92. Boston Scientific Corporation Latest Developments
Table 93. Boston Scientific Corporation Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 94. HeartWare International Product Offered
Table 95. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 96. HeartWare International Main Business
Table 97. HeartWare International Latest Developments
Table 98. HeartWare International Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 99. Biotronik SE & Co. KG Product Offered
Table 100. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 101. Biotronik SE & Co. KG Main Business
Table 102. Biotronik SE & Co. KG Latest Developments
Table 103. Biotronik SE & Co. KG Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 104. Medtronic Product Offered
Table 105. Medtronic Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 106. Medtronic Main Business
Table 107. Medtronic Latest Developments
Table 108. Medtronic Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 109. Jarvik Heart Product Offered
Table 110. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 111. Jarvik Heart Main Business
Table 112. Jarvik Heart Latest Developments
Table 113. Jarvik Heart Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 114. ReliantHeart Product Offered
Table 115. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 116. ReliantHeart Main Business
Table 117. ReliantHeart Latest Developments
Table 118. ReliantHeart Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
Table 119. LivaNova PLC Product Offered
Table 120. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2020E)
Table 121. LivaNova PLC Main Business
Table 122. LivaNova PLC Latest Developments
Table 123. LivaNova PLC Basic Information, Company Total Revenue (in $ million), Congestive Heart Failure (CHF) Treatment Devices Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Congestive Heart Failure (CHF) Treatment Devices
Figure 2. Congestive Heart Failure (CHF) Treatment Devices Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Congestive Heart Failure (CHF) Treatment Devices Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of Cardiac Resynchronization Therapy (CRT)
Figure 7. Product Picture of Implantable Cardioverter Defibrillators (ICDs)
Figure 8. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type (2015-2020)
Figure 9. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Type (2015-2020)
Figure 10. Congestive Heart Failure (CHF) Treatment Devices Consumed in Left Ventricular Assist Device (LVAD)
Figure 11. Global Congestive Heart Failure (CHF) Treatment Devices Market: Left Ventricular Assist Device (LVAD) (2015-2020) (K Units)
Figure 12. Global Congestive Heart Failure (CHF) Treatment Devices Market: Left Ventricular Assist Device (LVAD) (2015-2020) ($ Millions)
Figure 13. Congestive Heart Failure (CHF) Treatment Devices Consumed in Right Ventricular Assist Device (RVAD)
Figure 14. Global Congestive Heart Failure (CHF) Treatment Devices Market: Right Ventricular Assist Device (RVAD) (2015-2020) (K Units)
Figure 15. Global Congestive Heart Failure (CHF) Treatment Devices Market: Right Ventricular Assist Device (RVAD) (2015-2020) ($ Millions)
Figure 16. Congestive Heart Failure (CHF) Treatment Devices Consumed in Biventricular Assist Device (BIVAD)
Figure 17. Global Congestive Heart Failure (CHF) Treatment Devices Market: Biventricular Assist Device (BIVAD) (2015-2020) (K Units)
Figure 18. Global Congestive Heart Failure (CHF) Treatment Devices Market: Biventricular Assist Device (BIVAD) (2015-2020) ($ Millions)
Figure 19. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application (2015-2020)
Figure 20. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Application (2015-2020)
Figure 21. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company in 2017
Figure 22. Global Congestive Heart Failure (CHF) Treatment Devices Sales Market Share by Company in 2019
Figure 23. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company in 2017
Figure 24. Global Congestive Heart Failure (CHF) Treatment Devices Revenue Market Share by Company in 2019
Figure 25. Global Congestive Heart Failure (CHF) Treatment Devices Sale Price by Company in 2019
Figure 26. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Regions 2015-2020
Figure 27. Global Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Regions 2015-2020
Figure 28. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption 2015-2020 (K Units)
Figure 29. Americas Congestive Heart Failure (CHF) Treatment Devices Value 2015-2020 ($ Millions)
Figure 30. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption 2015-2020 (K Units)
Figure 31. APAC Congestive Heart Failure (CHF) Treatment Devices Value 2015-2020 ($ Millions)
Figure 32. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption 2015-2020 (K Units)
Figure 33. Europe Congestive Heart Failure (CHF) Treatment Devices Value 2015-2020 ($ Millions)
Figure 34. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption 2015-2020 (K Units)
Figure 35. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value 2015-2020 ($ Millions)
Figure 36. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries in 2019
Figure 37. Americas Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Countries in 2019
Figure 38. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type in 2019
Figure 39. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application in 2019
Figure 40. United States Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 41. United States Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 42. Canada Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 43. Canada Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 44. Mexico Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 45. Mexico Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 46. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries in 2019
Figure 47. APAC Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Regions in 2019
Figure 48. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type in 2019
Figure 49. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application in 2019
Figure 50. China Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 51. China Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 52. Japan Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 53. Japan Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 54. Korea Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 55. Korea Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 56. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 57. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 58. India Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 59. India Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 60. Australia Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 61. Australia Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 62. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries in 2019
Figure 63. Europe Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Countries in 2019
Figure 64. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type in 2019
Figure 65. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application in 2019
Figure 66. Germany Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 67. Germany Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 68. France Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 69. France Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 70. UK Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 71. UK Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 72. Italy Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 73. Italy Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 74. Russia Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 75. Russia Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 76. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Countries in 2019
Figure 77. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value Market Share by Countries in 2019
Figure 78. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Type in 2019
Figure 79. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Market Share by Application in 2019
Figure 80. Egypt Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 81. Egypt Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 82. South Africa Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 83. South Africa Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 84. Israel Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 85. Israel Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 86. Turkey Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 87. Turkey Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 88. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Consumption Growth 2015-2020 (K Units)
Figure 89. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Value Growth 2015-2020 ($ Millions)
Figure 90. Global Congestive Heart Failure (CHF) Treatment Devices Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 91. Global Congestive Heart Failure (CHF) Treatment Devices Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 92. Americas Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 93. Americas Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 94. APAC Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 95. APAC Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 96. Europe Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 97. Europe Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 98. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 99. Middle East & Africa Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 100. United States Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 101. United States Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 102. Canada Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 103. Canada Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 104. Mexico Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 105. Mexico Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 106. Brazil Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 107. Brazil Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 108. China Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 109. China Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 110. Japan Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 111. Japan Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 112. Korea Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 113. Korea Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 114. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 115. Southeast Asia Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 116. India Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 117. India Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 118. Australia Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 119. Australia Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 120. Germany Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 121. Germany Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 122. France Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 123. France Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 124. UK Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 125. UK Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 126. Italy Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 127. Italy Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 128. Russia Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 129. Russia Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 130. Spain Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 131. Spain Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 132. Egypt Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 133. Egypt Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 134. South Africa Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 135. South Africa Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 136. Israel Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 137. Israel Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 138. Turkey Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 139. Turkey Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 140. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Consumption 2021-2025 (K Units)
Figure 141. GCC Countries Congestive Heart Failure (CHF) Treatment Devices Value 2021-2025 ($ Millions)
Figure 142. Abiomed Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 143. Abbott Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 144. Berlin Heart GmbH Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 145. Boston Scientific Corporation Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 146. HeartWare International Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 147. Biotronik SE & Co. KG Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 148. Medtronic Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 149. Jarvik Heart Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 150. ReliantHeart Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Figure 151. LivaNova PLC Congestive Heart Failure (CHF) Treatment Devices Market Share (2018-2020)
Reason to Buy
- Current and future of Medical Devices & Consumables Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Medical Devices & Consumables Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Medical Devices & Consumables Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Medical Devices & Consumables Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets